{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:33:51Z","timestamp":1783953231290,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.encep.2023.11.023","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:52:54Z","timestamp":1708098774000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital"],"prefix":"10.1016","volume":"51","author":[{"given":"Foulques","family":"Icole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haghnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Jeannoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Besan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bronowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.encep.2023.11.023_bib0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gtc.2020.01.001","article-title":"Global epidemiology of viral hepatitis","volume":"49","author":"Razavi","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"issue":"1\u00a0Suppl.","key":"10.1016\/j.encep.2023.11.023_bib0125","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.encep.2023.11.023_bib0130","doi-asserted-by":"crossref","first-page":"a036921","DOI":"10.1101\/cshperspect.a036921","article-title":"Natural history of hepatic and extrahepatic hepatitis C virus diseases and impact of interferon-free HCV therapy","volume":"10","author":"Negro","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"10.1016\/j.encep.2023.11.023_bib0135","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.encep.2023.11.023_bib0140","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1186\/s12879-019-4493-2","article-title":"HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy","volume":"19","author":"Brouard","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.encep.2023.11.023_bib0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2215-0366(15)00357-0","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis","volume":"3","author":"Hughes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.encep.2023.11.023_bib0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.psychres.2017.08.036","article-title":"Increased risk of concurrent hepatitis C among male patients with schizophrenia","volume":"258","author":"Chiu","year":"2017","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.encep.2023.11.023_bib0155","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1503\/jpn.200154","article-title":"Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study","volume":"46","author":"Cheng","year":"2021","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.encep.2023.11.023_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12967-018-1542-3","article-title":"Association of viral hepatitis and bipolar disorder: a nationwide population-based study","volume":"16","author":"Chong","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.encep.2023.11.023_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.genhosppsych.2019.10.007","article-title":"Rates of hepatitis B and C in patients with schizophrenia: a meta-analysis","volume":"61","author":"Lluch","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2023.11.023_bib0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2215-0366(17)30253-5","article-title":"Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden","volume":"4","author":"Bauer-Staeb","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2023.11.023_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.encep.2020.03.003","article-title":"[Hepatitis C\u00a0in a psychiatric setting: a forgotten reservoir?]","volume":"47","author":"Rolland","year":"2021","journal-title":"Enc\u00e9phale"},{"issue":"10","key":"10.1016\/j.encep.2023.11.023_bib0180","first-page":"1237","article-title":"Prise en charge de l\u2019h\u00e9patite C en milieu psychiatrique\u00a0: revue de la litt\u00e9rature et retour d\u2019exp\u00e9rience sur quatre ann\u00e9es dans un centre hospitalier psychiatrique","volume":"28","author":"R\u00e9my","year":"2021","journal-title":"Hepato-Gastro Oncol Dig"},{"issue":"10","key":"10.1016\/j.encep.2023.11.023_bib0185","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jvh.13875","article-title":"Profile of patients with a positive HCV viral load in a large French psychiatric hospital (2019\u20132021): a case-control study","volume":"30","author":"Torres","year":"2023","journal-title":"J Viral Hepat"},{"issue":"8","key":"10.1016\/j.encep.2023.11.023_bib0190","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/liv.14537","article-title":"Global real-world evidence of sofosbuvir\/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts","volume":"40","author":"Mangia","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.encep.2023.11.023_bib0195","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/v14071541","article-title":"Real-world safety, effectiveness, and patient-reported outcomes in patients with chronic hepatitis C virus infection treated with glecaprevir\/pibrentasvir: updated data from the German Hepatitis C-Registry (DHC-R)","volume":"14","author":"Cornberg","year":"2022","journal-title":"Viruses"},{"issue":"10179","key":"10.1016\/j.encep.2023.11.023_bib0200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.encep.2023.11.023_bib0205","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.encep.2023.11.023_bib0210","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/pds.5576","article-title":"Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers","volume":"32","author":"Lam","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.encep.2023.11.023_bib0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2019.04.016","article-title":"Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study","volume":"71","author":"Evon","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.encep.2023.11.023_bib0220","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/jcm11113044","article-title":"Significant decrease in the prevalence of anxiety and depression after hepatitis C eradication","volume":"11","author":"Slonka","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.encep.2023.11.023_bib0225","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.1016\/S0168-8278(22)01479-9","article-title":"Benefits associated with HCV cure in people with mental disorders","volume":"77","author":"Rolland","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.encep.2023.11.023_bib0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.21734","article-title":"Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors","volume":"82","author":"Meffre","year":"2010","journal-title":"J Med Virol"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700624000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700624000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T02:29:39Z","timestamp":1739672979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700624000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0013700624000137"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2023.11.023","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2023.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}